Table 2.

Outcome measures by treatment group at each follow-up evaluationa,b

1-week1-month1-year
Sham, n= 65Interv, n= 62P-valueSham, n= 59Interv, n= 58P-valueSham, n= 54Interv, n= 59P-value
Not interviewed, n (%)3 (4.41)4 (6.06)0.7169 (13.24)8 (12.12)1.00014 (20.59)7 (10.61)0.154
Self-reported resolution of baseline vertigo ‘Yes’, n (%)19 (29.69)23 (37.10)0.45134 (57.63)36 (64.29)0.56741 (75.93)47 (87.04)0.215
Positive DHT, n (%)28 (43.08)22 (36.67)0.58420 (34.48)15 (25.86)0.4198 (14.81)10 (17.86)0.798
Positive DHT with nystagmus, n (%)14 (21.54)4 (6.67)0.02210 (16.95)4 (6.78)0.1533 (5.66)5 (10.00)0.480
Self-reported vertigo severity (Likert scale)5.00 (2.00–6.00)3.00 (1.00–5.00)0.0862.00 (0.50–4.50)1.00 (0.00–3.00)0.1000.00 (0.00–2.00)0.00 (0.00–1.00)0.703
  • a Results are shown as absolute figures and percentages for qualitative variables, and as median and interquartile range for quantitative variables.

  • b Positive DHT is vertigo and nystagmus. Global positive DHT is vertigo and nystagmus, or vertigo only. DHT = Dix–Hallpike test. Interv = intervention.